Literature DB >> 27817036

Freeze-all cycle for all normal responders?

Matheus Roque1,2, Marcello Valle3, Fernando Guimarães3, Marcos Sampaio4, Selmo Geber5,4.   

Abstract

PURPOSE: The purpose of this study is to evaluate the freeze-all strategy in subgroups of normal responders, to assess whether this strategy is beneficial regardless of ovarian response, and to evaluate the possibility of implementing an individualized embryo transfer (iET) based on ovarian response.
METHODS: This was an observational, cohort study performed in a private IVF center. A total of 938 IVF cycles were included in this study. The patients were submitted to controlled ovarian stimulation (COS) with a gonadotropin-releasing hormone (GnRH) antagonist protocol and a cleavage-stage day 3 embryo transfer. We performed a comparison of outcomes between the fresh embryo transfer (n = 523) and the freeze-all cycles (n = 415). The analysis was performed in two subgroups of patients based on the number of retrieved oocytes: Group 1 (4-9 oocytes) and Group 2 (10-15 oocytes). RESULT(S): In Group 1 (4-9 retrieved oocytes), the implantation rates (IR) were 17.9 and 20.5% (P = 0.259) in the fresh and freeze-all group, respectively; the ongoing pregnancy rates (OPR) were 31 and 33% (P = 0.577) in the fresh and freeze-all group, respectively. In Group 2 (10-15 oocytes), the IR were 22.1 and 30.1% (P = 0.028) and the OPR were 34 and 47% (P = 0.021) in the fresh and freeze-all groups, respectively. CONCLUSION(S): Although the freeze-all policy may be related to better in vitro fertilization (IVF) outcomes in normal responders, these potential advantages decrease with worsening ovarian response. Patients with poorer ovarian response do not benefit from the freeze-all strategy.

Entities:  

Keywords:  Delayed frozen-thawed embryo transfer; Elective frozen-thawed embryo transfer; Embryo cryopreservation; Freeze-all policy; IVF/ICSI

Mesh:

Substances:

Year:  2016        PMID: 27817036      PMCID: PMC5306402          DOI: 10.1007/s10815-016-0834-x

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  41 in total

1.  Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial.

Authors:  Abbas Aflatoonian; Homa Oskouian; Shahnaz Ahmadi; Leila Oskouian
Journal:  J Assist Reprod Genet       Date:  2010-04-06       Impact factor: 3.412

Review 2.  A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos.

Authors:  David H Edgar; Debra A Gook
Journal:  Hum Reprod Update       Date:  2012-04-25       Impact factor: 15.610

3.  Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates?

Authors:  Jane F Clarke; Minouche M E van Rumste; Cindy M Farquhar; Neil P Johnson; Ben W J Mol; Peter Herbison
Journal:  Fertil Steril       Date:  2010-01-13       Impact factor: 7.329

Review 4.  An OHSS-Free Clinic by segmentation of IVF treatment.

Authors:  Paul Devroey; Nikolaos P Polyzos; Christophe Blockeel
Journal:  Hum Reprod       Date:  2011-08-09       Impact factor: 6.918

Review 5.  Current status of human oocyte and embryo cryopreservation.

Authors:  Leyre Herrero; Mónica Martínez; Juan A Garcia-Velasco
Journal:  Curr Opin Obstet Gynecol       Date:  2011-08       Impact factor: 1.927

6.  Highly efficient vitrification method for cryopreservation of human oocytes.

Authors:  Masashige Kuwayama; Gábor Vajta; Osamu Kato; Stanley P Leibo
Journal:  Reprod Biomed Online       Date:  2005-09       Impact factor: 3.828

7.  Embryo development and gestation using fresh and vitrified oocytes.

Authors:  Carlos Gilberto Almodin; Vania Cibele Minguetti-Camara; Cassia Lopes Paixao; Priscila Cardoso Pereira
Journal:  Hum Reprod       Date:  2010-02-25       Impact factor: 6.918

Review 8.  Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.

Authors:  Charalampos Siristatidis; Theodoros N Sergentanis; Prodromos Kanavidis; Marialena Trivella; Marianthi Sotiraki; Ioannis Mavromatis; Theodora Psaltopoulou; Alkistis Skalkidou; Eleni Th Petridou
Journal:  Hum Reprod Update       Date:  2012-12-18       Impact factor: 15.610

9.  Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome.

Authors:  Zi-Jiang Chen; Yuhua Shi; Yun Sun; Bo Zhang; Xiaoyan Liang; Yunxia Cao; Jing Yang; Jiayin Liu; Daimin Wei; Ning Weng; Lifeng Tian; Cuifang Hao; Dongzi Yang; Feng Zhou; Juanzi Shi; Yongle Xu; Jing Li; Junhao Yan; Yingying Qin; Han Zhao; Heping Zhang; Richard S Legro
Journal:  N Engl J Med       Date:  2016-08-11       Impact factor: 91.245

10.  High ongoing pregnancy rates after deferred transfer through bipronuclear oocyte cryopreservation and post-thaw extended culture.

Authors:  Bruce S Shapiro; Said T Daneshmand; Forest C Garner; Martha Aguirre; Cynthia Hudson; Shyni Thomas
Journal:  Fertil Steril       Date:  2008-11-11       Impact factor: 7.329

View more
  11 in total

1.  To freeze or not to freeze: heating the debate but cooling the practice?

Authors:  Paolo F Rinaudo; John Hsu
Journal:  J Assist Reprod Genet       Date:  2017-01-14       Impact factor: 3.412

Review 2.  Fertility preservation in breast cancer with case-based examples for guidance.

Authors:  Mary E Hampe; Alice S Rhoton-Vlasak
Journal:  J Assist Reprod Genet       Date:  2020-02-01       Impact factor: 3.412

3.  Elevated serum progesterone does not impact euploidy rates in PGT-A patients.

Authors:  Maria Luisa Pardiñas; Mar Nohales; Elena Labarta; José María De Los Santos; Amparo Mercader; José Remohí; Ernesto Bosch; Maria José De Los Santos
Journal:  J Assist Reprod Genet       Date:  2021-05-18       Impact factor: 3.357

4.  Impact of elective frozen vs. fresh embryo transfer strategies on cumulative live birth: Do deleterious effects still exist in normal & hyper responders?

Authors:  Fazilet Kubra Boynukalin; Niyazi Emre Turgut; Meral Gultomruk; Selen Ecemis; Zalihe Yarkiner; Necati Findikli; Mustafa Bahceci
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

5.  Cumulative live birth rates following a 'freeze-all' strategy: a population-based study.

Authors:  Z Li; A Y Wang; M Bowman; K Hammarberg; C Farquhar; L Johnson; N Safi; E A Sullivan
Journal:  Hum Reprod Open       Date:  2019-03-05

6.  Fertility and Neonatal Outcomes of Freeze-All vs. Fresh Embryo Transfer in Women With Advanced Endometriosis.

Authors:  JIayi Wu; Xiaoyan Yang; Jiaan Huang; Yanping Kuang; Yun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

7.  Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study.

Authors:  Andrea Carosso; Alberto Revelli; Gianluca Gennarelli; Stefano Canosa; Stefano Cosma; Fulvio Borella; Annalisa Tancredi; Carlotta Paschero; Lara Boatti; Elisa Zanotto; Francesca Sidoti; Paolo Bottino; Cristina Costa; Rossana Cavallo; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2020-07-15       Impact factor: 3.412

8.  Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF.

Authors:  Andrea Roberto Carosso; Stefano Canosa; Gianluca Gennarelli; Marta Sestero; Bernadette Evangelisti; Lorena Charrier; Loredana Bergandi; Chiara Benedetto; Alberto Revelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-07

9.  Random sperm DNA fragmentation index is not associated with clinical outcomes in day-3 frozen embryo transfer.

Authors:  Qing-Xin Wang; Xia Wang; Min-Yan Yu; Hua Sun; Di Wang; Shu-Ping Zhong; Feng Guo
Journal:  Asian J Androl       Date:  2022 Jan-Feb       Impact factor: 3.285

10.  Association of the duration of post-thaw culture with clinical outcome after vitrified-warmed day 3 embryo transfer in 10,464 cycles: A retrospective cohort study.

Authors:  Haiyan Zhu; Wen Xu; Xiaoying Jin; Yamei Xue; Xiaomei Tong; Songying Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.